Cyclo Therapeutics Enters Research and Collaboration Agreement with Wits Commercial Enterprise (Pty) Ltd to Explore Potential Applications of Trappsol Cyclo to Expand Pipeline - Seite 2

The Collaboration consists of cooperative agreements in specific, undisclosed research and development, technology development and commercialization, and training projects, or any other activity agreed upon by Cyclo Therapeutics and Wits. Due to intellectual property development and for competitive reasons, Cyclo Therapeutics is not disclosing details related to the exploration of therapeutic areas or indications at this time.

“Wits Enterprise is a world-class organization and the go-to platform for Wits researchers needing support to capitalize their knowledge and research. We are excited to utilize and leverage their deep knowledge and expertise to further the advancement of Trappsol Cyclo and its potential to address additional areas of unmet clinical need,” added Lise Lund Kjems, MD, PhD, Chief Medical Officer of Cyclo Therapeutics.

Trappsol Cyclo is a proprietary formulation of hydroxypropyl beta cyclodextrin that, in multiple clinical studies, has shown encouraging results to effectively manage the transportation of cholesterol. Taking the place of the defective NPC1 protein, Trappsol Cyclo, with its cyclic structure, facilitates the transport of accumulated cholesterol out of cellular lysosomes so it can be further processed and excreted out of cells.

Cyclo Therapeutics is currently testing the investigational Trappsol Cyclo drug in a pivotal Phase 3 clinical trial and a long-term extension study for the treatment of Niemann-Pick disease Type C1, a rare, fatal and progressive genetic disorder and for the treatment of Alzheimer’s disease, an irreversible, progressive neurological disorder, in which high cholesterol is also implicated as a risk factor.

About Wits University

The University of the Witwatersrand is a leading research-intensive university in Africa, renowned for its academic and research excellence, and its commitment to social justice and the advancement of the public good. Located in Johannesburg (South Africa), the economic and industrial heartland of Africa, Wits University is committed to furthering its contribution to delivering high-level scarce skills for the global knowledge economy and building partnerships that will have a positive impact on society.